ICICI Bank (NYSE: IBN) director details extensive share and option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
ICICI Bank Ltd filed a Form 3 showing director Sandeep Batra’s existing stake and equity incentives. He directly holds 809,435 equity shares with par value Rs. 2 per share. The filing also lists multiple stock option awards at exercise prices from $14.67 down to $2.31.
Each stock option represents the contingent right to apply for one equity share. Footnotes describe grants made between 2013 and 2025, vesting in tranches and expiring between 2026 and 2033, with certain earlier tranches already fully exercised before their expiration dates.
Positive
- None.
Negative
- None.
Insider Trade Summary
14 transactions reported
Mixed
14 txns
Insider
Batra Sandeep
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Equity Shares, par value Rs. 2 per share | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 198,190 shares (Direct);
Equity Shares, par value Rs. 2 per share — 809,435 shares (Direct)
Footnotes (1)
- A total of 198,190 stock options granted on April 17, 2025 and vesting in three tranches: (i) 59,457 vesting on April 17, 2026 and expiring on April 16, 2031, (ii) 59,457 vesting on April 17, 2027 and expiring on April 16, 2032, and (iii) 79,276 vesting on April 17, 2028 and expiring on April 16, 2033. Each stock option represents the contingent right to apply for one Equity Share. The exercise prices of the stock options are denominated in Rupee and translated for convenience only into USD at the rate of INR92.47 to US$1.00, the exchange rate set forth int he H.10 statistical release of the Federal Reserve Board on March 13, 2026. A total of 196,000 stock options granted on April 26, 2024 and vesting in three tranches: (i) 58,800 vested on April 26, 2025 and expiring on April 25, 2030, (ii) 58,800 vesting on April 26, 2026 and lapsing on April 25, 2031, and (iii) 78,400 vesting on April 26, 2027 and expiring on April 25, 2032. A total of 231,000 stock options granted on April 21, 2023 and vesting in three tranches: (i) 69,300 vested on April 21, 2024 and expiring on April 20, 2029, (ii) 69,300 vested on April 21, 2025 and expiring on April 20, 2030, and (iii) 92,400 vesting on April 21, 2026 and expiring on April 20, 2031. A total of 249,100 stock options granted on April 23, 2022 and vesting in three tranches: (i) 74,730 vested on April 23, 2023 and expiring on April 22, 2028, (ii) 74,730 vested on April 23, 2024 and expiring on April 22, 2029, and (iii) 99,640 vested on April 23, 2025 and expiring on April 22, 2030. A total of 305,350 stock options granted on April 24, 2021 and vesting in three tranches: (i) 91,605 vested on April 24, 2022 and expiring on April 23, 2027, (ii) 91,605 vested on April 24, 2023 and expiring on April 23, 2028, and (iii) 122,140 vested on April 24, 2024 and expiring on April 23, 2029. A total of 610,500 stock options granted on May 9, 2020 and vesting in three tranches: (i) 183,150 vested on May 9, 2021 and expiring on May 8, 2026, which have been fully exercised by the Reporting Person prior to expiration, (ii) 183,150 vested on May 9, 2022 and expiring on May 8, 2027, and (iii) 244,200 vested on May 9, 2023 and expiring on May 8, 2028. A total of 449,500 stock options granted on May 6, 2019 and vesting in three tranches: (i) 134,850 vested on May 6, 2020 and expired on May 5, 2025, which have been fully exercised by the Reporting Person prior to expiration, (ii) 134,850 vested on May 6, 2021 and expiring on May 5, 2026, which have been fully exercised by the Reporting Person prior to expiration, and (iii) 179,800 vested on May 6, 2022 and expiring on May 5, 2027. A total of 202,125 stock options granted on May 3, 2017 and vesting in three tranches: (i) 60,638 vested on May 3, 2018 and expiring on May 2, 2028, (ii) 60,637 vested on May 3, 2019 and expiring on May 2, 2029, and (iii) 80,850 vested on May 3, 2020 and expiring on May 2, 2030. A total of 256,025 stock options granted on April 28, 2016 and vesting in three tranches: (i) 76,808 vested on April 28, 2017 and expiring on April 27, 2027, (ii) 76,807 vested on April 28, 2018 and expiring on April 27, 2028, and (iii) 102,410 vested on April 28, 2019 and expiring on April 27, 2029. A total of 404,250 stock options granted on September 16, 2015 and vesting in two tranches: (i) 202,125 vested on April 30, 2018 and expiring on April 29, 2028 and (ii) 202,125 vested on April 30, 2019 and expiring on April 29, 2029. A total of 269,500 stock options granted on April 27, 2015 and vesting in three tranches: (i) 80,850 vested on April 27, 2016 and expiring on April 26, 2026, which have been fully exercised by the Reporting Person prior to expiration, (ii) 80,850 vested on April 27, 2017 and expiring on April 26, 2027, and (iii) 107,800 vested on April 27, 2018 and expiring on April 26, 2028. A total of 269,500 stock options granted on April 25, 2014 and vesting in three tranches: (i) 80,850 vested on April 25, 2015 and expired on April 24, 2025, which have been fully exercised by the Reporting Person prior to expiration, (ii) 80,850 vested on April 25, 2016 and expiring on April 24, 2026, which have been fully exercised by the Reporting Person prior to expiration, and (iii) 107,800 vested on April 25, 2017 and expiring on April 24, 2027. A total of 233,750 stock options granted on April 26, 2013 and vesting in four tranches: (i) 46,750 vested on April 26, 2014 and expired on April 25, 2024 which have been fully exercised by the Reporting Person prior to expiration, (ii) 46,750 vested on April 26, 2015 and expired on April 25, 2025, which have been fully exercised by the Reporting Person prior to expiration, (iii) 70,125 vested on April 26, 2016 and expiring on April 25, 2026, which have been fully exercised by the Reporting Person prior to expiration, and (iv) 70,125 vested on April 26, 2017 and expiring on April 25, 2027.
FAQ
What does ICICI Bank (IBN) director Sandeep Batra’s Form 3 report?
The Form 3 reports Sandeep Batra’s existing ownership in ICICI Bank, not new trades. It shows direct holdings of 809,435 equity shares plus multiple stock option grants with various exercise prices, vesting schedules, and expirations extending out to 2033.
What stock option grants for ICICI Bank (IBN) are disclosed for Sandeep Batra?
The filing lists several option awards, including 198,190 options with an exercise price of $14.67 and 196,000 options at $12.04. Additional grants cover underlying share amounts from 70,125 to 427,350 equity shares at lower exercise prices.
What do Sandeep Batra’s ICICI Bank (IBN) stock options entitle him to?
Each option represents a contingent right to apply for one equity share of ICICI Bank. The rights become exercisable based on the vesting schedules described in the footnotes and remain exercisable until their specified expiration dates, assuming they are not already fully exercised.
Over what period do ICICI Bank (IBN) stock options for Sandeep Batra vest and expire?
The options were granted between 2013 and 2025 and generally vest in two or three tranches. Footnotes show expirations ranging from 2026 to 2033, with several earlier tranches noted as already fully exercised before their respective expiration dates.
Are any of Sandeep Batra’s older ICICI Bank (IBN) option grants already exercised?
Yes. Footnotes state that certain tranches from grants in 2013, 2014, 2015, 2019, and 2020 have been fully exercised before their expiration dates, while later tranches from those grants and newer awards remain outstanding and continue to be exercisable over time.